Respiratory
Credibility 80
Tezepelumab in real-world US patients with severe asthma across phenotypes and underrepresented populations: the phase 4 PASSAGE study.
September 1, 2026 · American journal of respiratory and critical care medicine
Key takeaway
This study found a new asthma treatment, tezepelumab, significantly reduced severe asthma attacks and improved breathing for people, including Black adults, who often face worse asthma outcomes. This is important because it shows effective treatments are available and work well for our community, offering better control over severe asthma.
Why this matters for our communities
Research in respiratory helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Respiratory
December 4, 2026An examination of self-efficacy as a mediator of the relationship between asthma knowledge and self-management in urban adolescents.Read October 13, 2026Health Supports Learning: Academic Outcomes Improved by the School-Based Asthma Therapy Program.Read October 5, 2026Exploring Black Mothers' Lived Experiences of Depression and the Relationship to Their Child's Asthma: A Qualitative Study.Read